Versaflex™ HC and Versaflex HC BIO Thermoplastic Elastomers (TPEs): These specialty TPE formulations offer versatile and customizable performance for medical and biopharmaceutical tubing, device overmolds, and injection molded applications. Available in a variety of durometers and performance characteristics, the product family includes grades formulated without animal derivatives and a bio-based Versaflex HC BIO BT218 formulation developed specifically to handle the complexities of biopharmaceutical tubing (excellent weldability, kink resistance, and low levels of leachables and extractables) with a lower carbon footprint than traditional Versaflex HC TPE or silicone alternatives.

Avient Corporation highlights sustainable innovations at NPE 2024, including Nymax™ REC Recycled Nylon Formulations, Versaflex™ HC BIO BT218 TPEs, ColorMatrix™ Capture™ Oxygen Scavenger, and Cesa™ Non-PFAS Process Aid for Extrusion, exemplifying the company’s commitment to delivering advanced sustainable solutions.   Versaflex™ HC BIO BT218 TPEs: a finalist for the Plastics Industry Association’s People’s Choice for Plastics Sustainability Innovation Award to be announced at NPE, this grade of bio-derived thermoplastic elastomer (TPE) is developed specifically to handle the complexities of biopharmaceutical tubing and deliver excellent weldability, kink resistance, and low levels of extractables while offering the same performance as its prime counterpart but with a lower carbon footprint.

Completed acquisition of Kraton's TPE business in first quarter 2016 said, "With our recent refinancing, I'm extremely pleased to report we achieved a substantial reduction in our stated interest rates, extended maturities and improved our credit profile.  I'm excited to kick-off 2016 with our acquisition of Kraton's thermoplastic elastomer (TPE) business," Mr.

Sources Cash from Balance Sheet $465 New Senior Unsecured Notes 650 New Equity 450 Total Sources $1,565 Uses Clariant Masterbatch $1,500 Clariant India Masterbatch 60 Less: Lease Adjustment (113) Net Purchase Price $1,447 Net Cash Acquired 57 Fees, Expenses & OID 61 Total Uses $1,565 ($ Millions) Cash and Cash Equivalents $370 $450M Senior Secured ABL Revolver - Senior Secured Term Loan B due 2026 624 Other Debt 25 Total Senior Secured Debt $649 5.25% Senior Unsecured Notes due 2023 $600 New Senior Unsecured Notes 650 Total Senior Debt $1,899 Net Debt $1,529 New Equity $450 Pro Forma Capitalization (1) PF 12/31/2019 $450 $600 $624 $743 2019 2020 2021 2022 2023 2024 2025 2026 A T T R A C T I V E F I N A N C I N G S T R U C T U R E Attractive Debt Maturity Profile Existing Revolver Existing Senior Notes Existing Term Loan B New Debt Summary Terms on New Debt  $465 million of cash from the balance sheet expected to fund a portion of the purchase price  Bridge financing for remainder fully committed from Citi, Morgan Stanley and Wells Fargo  Permanent financing expected to include a combination of long-term debt and new equity  The timing of the permanent financing is subject to a number of factors, including, but not limited to, market conditions  PolyOne is committed to preserving a strong balance sheet – Target net leverage at close below 3.5x, excluding synergies  Pro forma capital structure positions PolyOne with flexibility to pursue continued growth strategy  New financing expected to have same or better covenant package than existing capital structure  Capital structure would be “covenant lite” Capital Policy  Transaction in line with PolyOne’s disciplined capital allocation policy  Existing PolyOne dividend policy to be maintained  Focus on deleveraging in the near term 2028+ PolyOne Corporation 26 PolyOne Corporation 27 T H E N E W P O L Y O N E : A S P E C I A L T Y G R O W T H C O M P A N Y  Landmark portfolio transformation: > 85% of Adjusted EBITDA from specialty solutions  World-class innovation, technology and service are differentiators  Sustainability initiatives and alignment with megatrends drive above market growth in key end markets and applications:  Capital management is a strength - proven track record of expanding ROIC while increasing invested capital Transaction expected to add $0.85 to pro forma adjusted EPS PolyOne Corporation 28 PolyOne Corporation 29

Maintain asset-light, 80% free cash flow conversion profile 5.

Maintain asset-light, 80% free cash flow conversion profile 5.

TPE BIO-CUP BEIGE 2309C TPE BIO-CUP BROWN 4225C

TRANS PURPLE HAZE TPE TRANS WILD SALMON TPE

TPE BLUE-GREEN RED TPE CC

TPE BLUE #3 TPE RED-VIOLET